Literature DB >> 6213213

Pulmonary artery atherosclerosis: correlation with systemic atherosclerosis and hypertensive pulmonary vascular disease.

G W Moore, R R Smith, G M Hutchins.   

Abstract

Atherosclerosis of the pulmonary arteries is a common autopsy finding and is associated with a variety of clinical conditions. To delineate the morphologic changes associated with pulmonary artery atherosclerosis, autopsies of 337 consecutive adults (greater than 15 years of age) were studied. For each, 35 features were studied, including age, coronary vascular disease, cardiac chamber hypertrophy and dilation, pulmonary artery and aortic atherosclerosis, and pulmonary thromboemboli and emphysema. These were compared using correlation coefficients and forward and backward stepwise regression procedures for selected variables. Pulmonary artery atherosclerosis correlated significantly with age, right ventricular dilation and hypertrophy, pulmonary emphysema, and aortic atherosclerosis. Regional evaluations of systemic and pulmonary atherosclerosis showed highly significant internal correlations. In the ligamentum arteriosum, the intensity of atherosclerosis over the aortic insertion correlated with the severity of a similar atheroma at the pulmonary artery insertion. With the multiple-regression procedure, pulmonary artery atherosclerosis was a significant predictor of aortic atherosclerosis, right ventricular hypertrophy, and pulmonary embolization. Our study shows that pulmonary embolization. Our study shows that pulmonary embolization. Our study shows that pulmonary artery atherosclerosis is accelerated in patients with atherosclerosis of the systemic arteries and the pathologic lesions associated with hypertensive pulmonary vascular disease.

Entities:  

Mesh:

Year:  1982        PMID: 6213213

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  12 in total

Review 1.  Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.

Authors:  P Egermayer; G I Town; A J Peacock
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

2.  Intermittent hypoxia and hypercapnia induces inhibitor of nuclear factor-κB kinase subunit β-dependent atherosclerosis in pulmonary arteries.

Authors:  Toshihiro Imamura; Jin Xue; Orit Poulsen; Dan Zhou; Michael Karin; Gabriel G Haddad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-16       Impact factor: 3.619

3.  Statins and the risk of idiopathic venous thromboembolism.

Authors:  Chen-Chang Yang; Susan S Jick; Hershel Jick
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

Review 4.  Role of oxidized lipids in pulmonary arterial hypertension.

Authors:  Salil Sharma; Grégoire Ruffenach; Soban Umar; Negar Motayagheni; Srinivasa T Reddy; Mansoureh Eghbali
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

5.  Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation.

Authors:  E Arbustini; P Morbini; A M D'Armini; A Repetto; G Minzioni; F Piovella; M Viganó; L Tavazzi
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

6.  Intermittent Hypoxia and Hypercapnia Accelerate Atherosclerosis, Partially via Trimethylamine-Oxide.

Authors:  Jin Xue; Dan Zhou; Orit Poulsen; Toshihiro Imamura; Yu-Hsin Hsiao; Travis H Smith; Atul Malhotra; Pieter Dorrestein; Rob Knight; Gabriel G Haddad
Journal:  Am J Respir Cell Mol Biol       Date:  2017-11       Impact factor: 6.914

7.  Global quantification of pulmonary artery atherosclerosis using 18F-sodium fluoride PET/CT in at-risk subjects.

Authors:  Vincent Zhang; Austin J Borja; Chaitanya Rojulpote; Sayuri Padmanabhan; Shivaraj Patil; Karthik Gonuguntla; Mona-Elisabeth Revheim; Thomas J Werner; Poul F Høilund-Carlsen; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-04-15

8.  (18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle study.

Authors:  Guy Hagan; Mark Southwood; Carmen Treacy; Robert Mackenzie Ross; Elaine Soon; James Coulson; Karen Sheares; Nicholas Screaton; Joanna Pepke-Zaba; Nicholas W Morrell; James H F Rudd
Journal:  Pulm Circ       Date:  2011 Oct-Dec       Impact factor: 3.017

9.  Diabetes, aging, and tuberculosis.

Authors:  Carlos Pérez-Guzmán; Mario H Vargas
Journal:  Lung India       Date:  2011-07

10.  Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease.

Authors:  Mariana Muñoz-Esquerre; Marta López-Sánchez; Ignacio Escobar; Daniel Huertas; Rosa Penín; María Molina-Molina; Frederic Manresa; Jordi Dorca; Salud Santos
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.